Luvometinib in patients with Langerhans cell histiocytosis, Erdheim–Chester disease, and other histiocytic neoplasms: a single-arm, multicentre, phase 2 study

Authors

Jie Ma (ORCID: https://orcid.org/0000-0002-3900-1903)
Zheng Yang (ORCID: https://orcid.org/0000-0003-1898-2260)
Zhen Wei (ORCID: https://orcid.org/0000-0003-4377-9993)
Xingli Wang (ORCID: https://orcid.org/0000-0003-2785-9707)
Xinxin Cao (ORCID: https://orcid.org/0000-0001-7884-3073)
Hui Zhou (ORCID: https://orcid.org/0000-0001-9909-5051)
Pu Han
Zhen Cai (ORCID: https://orcid.org/0000-0001-6647-0310)
Lai‐ping Zhong (ORCID: https://orcid.org/0000-0002-5528-9169)
Jiayan Guo
Jian Li (ORCID: https://orcid.org/0000-0002-4549-0694)
Qi Zhu (ORCID: https://orcid.org/0000-0003-1195-4582)
Zhuli Wu
Hongmei Lin (ORCID: https://orcid.org/0000-0001-5368-0474)
Long Chang (ORCID: https://orcid.org/0000-0002-1026-016X)

Institutions

Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
Fudan University (CN)
Peking Union Medical College Hospital (CN)
Shanghai Ninth People's Hospital (CN)
Fosun Pharma (China) (CN)
Hunan Cancer Hospital (CN)
First Affiliated Hospital of Zhengzhou University (CN)
Huashan Hospital (CN)
First Affiliated Hospital Zhejiang University (CN)

Publication Details

Journal: EClinicalMedicine
Published: 2025-09-17
DOI: https://doi.org/10.1016/j.eclinm.2025.103486
Citations: 1
Primary Topic: Histiocytic Disorders and Treatments
Type: article
Field-Weighted Citation Impact: 1.16

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Luvometinib in patients with Langerhans cell histiocytosis, Erdheim–Chester disease, and other histiocytic neoplasms: a single-arm, multicentre, phase 2 study

Jie Ma, Zheng Yang, Zhen Wei, Xingli Wang et al.

Sep 17, 2025

1 citations

EClinicalMedicine

Histiocytic Disorders and Treatments

1.16

article

Luvometinib in patients with Langerhans cell histiocytosis, Erdheim–Chester disease, and other histiocytic neoplasms: a single-arm, multicentre, phase 2 study

Jie Ma, Zheng Yang, Zhen Wei, Xingli Wang, Xinxin Cao, Hui Zhou, Pu Han, Zhen Cai, Lai‐ping Zhong, Jiayan Guo, Jian Li, Qi Zhu, Zhuli Wu, Hongmei Lin, Long Chang

September 17, 2025article en

1 citations

Abstract

No abstract available for this paper.

EClinicalMedicineVol. 88

Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Fudan University (CN), Peking Union Medical College Hospital (CN), Shanghai Ninth People's Hospital (CN), Fosun Pharma (China) (CN), Hunan Cancer Hospital (CN), First Affiliated Hospital of Zhengzhou University (CN), Huashan Hospital (CN), First Affiliated Hospital Zhejiang University (CN)

Openalex Percentile: Top 18%

Histiocytic Disorders and Treatments

1.16

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Luvometinib in patients with Langerhans cell histiocytosis, Erdheim–Chester disease, and other histiocytic neoplasms: a single-arm, multicentre, phase 2 study — Jie Ma, Zheng Yang, et al. · EClinicalMedicine (2025) | TGRS Research Map | TGRS